Yusheng Liu

1.4k total citations
45 papers, 1.0k citations indexed

About

Yusheng Liu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yusheng Liu has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Yusheng Liu's work include Reproductive System and Pregnancy (6 papers), Immunotherapy and Immune Responses (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Yusheng Liu is often cited by papers focused on Reproductive System and Pregnancy (6 papers), Immunotherapy and Immune Responses (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Yusheng Liu collaborates with scholars based in China, United States and Taiwan. Yusheng Liu's co-authors include Hua Wang, Li Wu, Guixiang Zhou, Xianhong Tong, Bo Yang, Guoping He, Bo Xu, Hongmei Wang, Xiaoqing Yi and Qing Li and has published in prestigious journals such as Nature Communications, Biomaterials and Advanced Functional Materials.

In The Last Decade

Yusheng Liu

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusheng Liu China 18 386 231 216 172 113 45 1.0k
Vahid Younesi Iran 17 364 0.9× 349 1.5× 62 0.3× 96 0.6× 159 1.4× 37 1.0k
Jae Hoon Lee South Korea 20 212 0.5× 361 1.6× 416 1.9× 184 1.1× 113 1.0× 109 1.2k
Polina Vishnyakova Russia 17 369 1.0× 331 1.4× 88 0.4× 46 0.3× 96 0.8× 81 1.1k
Katarzyna Smolarczyk Poland 15 205 0.5× 252 1.1× 425 2.0× 274 1.6× 75 0.7× 25 1.1k
Mohammad Sadegh Soltani‐Zangbar Iran 20 449 1.2× 334 1.4× 137 0.6× 185 1.1× 54 0.5× 77 1.0k
Karin Kunzi‐Rapp Germany 12 158 0.4× 294 1.3× 123 0.6× 117 0.7× 113 1.0× 24 855
Junko Inagaki Japan 18 341 0.9× 260 1.1× 110 0.5× 42 0.2× 77 0.7× 45 936
Chang‐Ching Yeh Taiwan 14 304 0.8× 281 1.2× 60 0.3× 108 0.6× 77 0.7× 37 939
Jae Hee Lee South Korea 17 234 0.6× 278 1.2× 117 0.5× 58 0.3× 123 1.1× 43 888
Peter Sedlmayr Austria 28 966 2.5× 386 1.7× 207 1.0× 345 2.0× 317 2.8× 69 2.0k

Countries citing papers authored by Yusheng Liu

Since Specialization
Citations

This map shows the geographic impact of Yusheng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusheng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusheng Liu more than expected).

Fields of papers citing papers by Yusheng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusheng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusheng Liu. The network helps show where Yusheng Liu may publish in the future.

Co-authorship network of co-authors of Yusheng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yusheng Liu. A scholar is included among the top collaborators of Yusheng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusheng Liu. Yusheng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dwivedy, Abhisek, Wei Hong, Abhichart Krissanaprasit, et al.. (2025). Engineering Novel DNA Nanoarchitectures for Targeted Drug Delivery and Aptamer Mediated Apoptosis in Cancer Therapeutics. Advanced Functional Materials. 35(22). 5 indexed citations
2.
Liu, Yusheng, et al.. (2025). Injectable extracellular vesicle hydrogels with tunable viscoelasticity for depot vaccine. Nature Communications. 16(1). 3781–3781. 8 indexed citations
3.
Liu, Yusheng, Zheng Chen, NU Lin, Yu Liu, & Xuefeng Jiang. (2025). Evaluating the psychosocial effects of cancer on sleep quality and mental health in elderly populations. BMC Psychiatry. 25(1). 933–933.
4.
Liu, Yusheng, Chunying Wu, Qiang Wang, Xiaoshan Zhao, & Xuefeng Jiang. (2025). NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses. Scientific Reports. 15(1). 18812–18812. 1 indexed citations
5.
Liu, Yusheng, Junfeng Zhang, Chunying Wu, et al.. (2024). Nanoplatform based on carbon nanoparticles loaded with doxorubicin enhances apoptosis by generating reactive oxygen species for effective cancer therapy. Oncology Letters. 27(6). 288–288. 1 indexed citations
6.
Yang, Bo, et al.. (2024). Primary adipocytes as targetable drug depot to prevent post-surgical cancer recurrence. Materials Today Bio. 25. 101020–101020.
7.
Liu, Yusheng, Bo Yang, David Lee, et al.. (2023). Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines. Nature Communications. 14(1). 8047–8047. 53 indexed citations
8.
Liu, Yusheng, et al.. (2023). Application of Silk-Fibroin-Based Hydrogels in Tissue Engineering. Gels. 9(5). 431–431. 45 indexed citations
9.
Liu, Yusheng, et al.. (2023). Effect of Hypoxia Conditioning on Body Composition in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis. Sports Medicine - Open. 9(1). 89–89. 7 indexed citations
10.
Liu, Yusheng & Hua Wang. (2023). Biomarkers and targeted therapy for cancer stem cells. Trends in Pharmacological Sciences. 45(1). 56–66. 31 indexed citations
11.
Liu, Yusheng, et al.. (2022). Targeted delivery of liposomal chemoimmunotherapy for cancer treatment. Frontiers in Immunology. 13. 8 indexed citations
12.
Gao, Y., et al.. (2022). A Robust and Highly Efficient Approach for Isolation of Mesenchymal Stem Cells From Wharton’s Jelly for Tissue Repair. Cell Transplantation. 31. 4221142210–4221142210. 10 indexed citations
13.
Wang, Jianyong, Yusheng Liu, Yao Liu, et al.. (2022). Surgical resection of pediatric PRETEXT III and IV hepatoblastoma: A retrospective study investigating the need for preoperative chemotherapy. Frontiers in Pediatrics. 10. 878095–878095. 4 indexed citations
14.
Liu, Yusheng, et al.. (2020). Variations of the right branch of hepatic portal vein in children based on three-dimensional simulation technology. Surgical and Radiologic Anatomy. 42(12). 1467–1473. 2 indexed citations
15.
Jiang, Xuefeng, et al.. (2020). Long Noncoding RNA Serve as a Potential Predictive Biomarker for Breast Cancer: A Meta‐Analysis. BioMed Research International. 2020(1). 9045786–9045786. 7 indexed citations
16.
Wang, Jian, et al.. (2018). Feasibility analysis of treating severe intrauterine adhesions by transplanting menstrual blood-derived stem cells. International Journal of Molecular Medicine. 41(4). 2201–2212. 43 indexed citations
17.
Liu, Yusheng, et al.. (2011). The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human neuroblastoma. Zhonghua xiaoerwaike zazhi. 32(2). 129–134. 1 indexed citations
18.
Sheng, Yuanjian, Jie Gao, Wenlong Hu, et al.. (2010). Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. Lara D. Veeken. 50(4). 682–688. 51 indexed citations
19.
Liu, Yusheng, et al.. (2010). Study on the Relationship Between Th17 Cells and Unexplained Recurrent Spontaneous Abortion. American Journal of Reproductive Immunology. 65(5). 503–511. 129 indexed citations
20.
Lu, Jean, Shaoyin Chen, Huey‐Huey Chua, et al.. (2000). Upregulation of Tyrosine Kinase TKT by the Epstein-Barr Virus Transactivator Zta. Journal of Virology. 74(16). 7391–7399. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026